Terms: = Cervical cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID
113 results:
1. Identification and Quantification of Radiotherapy-related Protein Expression in cancer Tissues Using the Qupath Software and Prediction of Treatment Response.
Hasegawa T; Someya M; Tsuchiya T; Kitagawa M; Fukushima Y; Gocho T; Mafune S; Okuda R; Kaguchi J; Ohguro A; Kamiyama R; Ashina A; Toshima Y; Hirohashi Y; Torigoe T; Sakata KI
In Vivo; 2024; 38(3):1470-1476. PubMed ID: 38688633
[TBL] [Abstract] [Full Text] [Related]
2.
Zou Q; Wu Y; Zhang S; Li S; Li S; Su Y; Zhang L; Li Q; Zou H; Zhang X; Wang T; Liang S; Yang J; Li C
Virulence; 2024 Dec; 15(1):2319962. PubMed ID: 38380669
[TBL] [Abstract] [Full Text] [Related]
3. IL-10
Yang C; Zhang Y; Wang R; Cheng B; Wu Y; Fu X
Autoimmunity; 2024 Dec; 57(1):2290909. PubMed ID: 38084896
[TBL] [Abstract] [Full Text] [Related]
4. Regulatory T cell frequency in peripheral blood of women with advanced cervical cancer including women living with HIV.
Chetty-Sebastian D; Assounga AG
BMC Cancer; 2023 Sep; 23(1):830. PubMed ID: 37670247
[TBL] [Abstract] [Full Text] [Related]
5. Brachytherapy for targeting the immune system in cervical cancer patients.
Linares I; Berenguer Frances MÁ; Cañas R; Najjari D; Gutiérrez C; Marín S; Comas S; Guedea F; Pujol M
BMC Immunol; 2023 Aug; 24(1):23. PubMed ID: 37559025
[TBL] [Abstract] [Full Text] [Related]
6. Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial.
Rodrigues M; Vanoni G; Loap P; Dubot C; Timperi E; Minsat M; Bazire L; Durdux C; Fourchotte V; Laas E; Pouget N; Castel-Ajgal Z; Marret G; Lesage L; Meseure D; Vincent-Salomon A; Lecompte L; Servant N; Vacher S; Bieche I; Malhaire C; Huchet V; Champion L; Kamal M; Amigorena S; Lantz O; Chevrier M; Romano E
Nat Commun; 2023 Jun; 14(1):3698. PubMed ID: 37349318
[TBL] [Abstract] [Full Text] [Related]
7. Infection pattern and immunological characteristics of Epstein-Barr virus latent infection in cervical squamous cell carcinoma.
Zuo Y; Xiao H; Lv D; Huang M; Wang L; Liu J; Zhang K; Shen J; Wang Z; Wu Q; Xu Y
J Med Virol; 2023 Apr; 95(4):e28717. PubMed ID: 37184049
[TBL] [Abstract] [Full Text] [Related]
8. Contribution of HLA-G and foxp3 genes and proteins in the severity of cervical intraepithelial neoplasia during HPV infection.
da Silva NCH; Sonon P; Medeiros FS; da Silva MC; Dos Santos Gomes FO; Peixoto CA; Crispim JCO; Paiva LA; Rygaard MCV; Menezes MLB; Welkovic S; Donadi EA; Lucena-Silva N
Hum Immunol; 2023 Aug; 84(8):408-417. PubMed ID: 37149423
[TBL] [Abstract] [Full Text] [Related]
9. Mesenchymal Stem/Stromal Cells Derived from cervical cancer Promote M2 Macrophage Polarization.
Cortés-Morales VA; Chávez-Sánchez L; Rocha-Zavaleta L; Espíndola-Garibay S; Monroy-García A; Castro-Manrreza ME; Fajardo-Orduña GR; Apresa-García T; Gutiérrez-de la Barrera M; Mayani H; Montesinos JJ
Cells; 2023 Mar; 12(7):. PubMed ID: 37048119
[TBL] [Abstract] [Full Text] [Related]
10. Increase of the T-reg-recruiting chemokine CCL22 expression in a progressive course of cervical dysplasia.
Vattai A; Kremer N; Meister S; Beyer S; Keilmann L; Buschmann C; Corradini S; Schmoeckel E; Kessler M; Mahner S; Jeschke U; Hertlein L; Kolben T
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6613-6623. PubMed ID: 36792811
[TBL] [Abstract] [Full Text] [Related]
11. Integrated single-cell transcriptome analysis of the tumor ecosystems underlying cervical cancer metastasis.
Li C; Liu D; Yang S; Hua K
Front Immunol; 2022; 13():966291. PubMed ID: 36569924
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy and Synergy with Cisplatin of an Adenovirus Vectored Therapeutic E1E2E6E7 Vaccine against HPV Genome-Positive C3 cancers in Mice.
Boilesen DR; Neckermann P; Willert T; Müller MD; Schrödel S; Pertl C; Thirion C; Asbach B; Wagner R; Holst PJ
Cancer Immunol Res; 2023 Feb; 11(2):261-275. PubMed ID: 36534088
[TBL] [Abstract] [Full Text] [Related]
13. Predictive value of an exosomal microRNA-based signature for tumor immunity in cervical cancer patients treated with chemoradiotherapy.
Someya M; Hasegawa T; Tsuchiya T; Kitagawa M; Fukushima Y; Gocho T; Mafune S; Ikeuchi Y; Kozuka Y; Idogawa M; Hirohashi Y; Torigoe T; Iwasaki M; Matsuura M; Saito T; Sakata KI
Med Mol Morphol; 2023 Mar; 56(1):38-45. PubMed ID: 36367588
[TBL] [Abstract] [Full Text] [Related]
14. Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions.
Abdulrahman Z; Hendriks N; J Kruse A; Somarakis A; J M van de Sande A; J van Beekhuizen H; M J Piek J; de Miranda NFCC; Kooreman LFS; F M Slangen B; van der Burg SH; de Vos van Steenwijk PJ; van Esch EMG
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36323430
[TBL] [Abstract] [Full Text] [Related]
15. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating foxp3 transcription in cervical cancer.
Ni H; Zhang H; Li L; Huang H; Guo H; Zhang L; Li C; Xu JX; Nie CP; Li K; Zhang X; Xia X; Li J
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36126994
[TBL] [Abstract] [Full Text] [Related]
16. Multiparametric immune profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: an exploratory study of the CLAP trial.
Wang Y; Lai Y; Peng H; Yan S; Liu Z; Tong C; Huang X
Clin Transl Oncol; 2023 Jan; 25(1):256-268. PubMed ID: 36115931
[TBL] [Abstract] [Full Text] [Related]
17. Genetic association study of intron variants in the forkhead box protein P3 gene in Chinese patients diagnosed with cervical cancer.
Shi F; Pang XX; Li GJ; Chen ZH; Dong MY; Wang JL
J Cell Mol Med; 2022 May; 26(9):2658-2672. PubMed ID: 35322929
[TBL] [Abstract] [Full Text] [Related]
18. Role of foxp3-positive regulatory T-cells in regressive and progressive cervical dysplasia.
Vattai A; Kremer N; Meister S; Beyer S; Keilmann L; Hester A; Temelkov M; Heidegger H; Schmoeckel E; Kessler M; Mahner S; Jeschke U; Hertlein L; Kolben T
J Cancer Res Clin Oncol; 2022 Feb; 148(2):377-386. PubMed ID: 34739585
[TBL] [Abstract] [Full Text] [Related]
19. Identifying a cervical cancer survival signature based on mRNA expression and genome-wide copy number variations.
Li N; Yu K; Lin Z; Zeng D
Exp Biol Med (Maywood); 2022 Feb; 247(3):207-220. PubMed ID: 34674573
[TBL] [Abstract] [Full Text] [Related]
20. B7-H4 Expression in Precancerous Lesions of the Uterine Cervix.
Zhang Q; Zong L; Zhang H; Xie W; Yang F; Sun W; Cui B; Zhang Y
Biomed Res Int; 2021; 2021():5857092. PubMed ID: 34651047
[TBL] [Abstract] [Full Text] [Related]
[Next]